Bart van der Worp is a neurologist with a special interest in cerebrovascular diseases at the University Medical Center in Utrecht, the Netherlands. He has been (co-)Chief Investigator of the randomised clinical trials HAMLET, PAIS, COOLIST, and VAST and is (co-)Chief Investigator of PRECIOUS (www.precious-trial.eu), APACHE-AF (www.apache-af.nl), and – starting shortly – MR ASAP. He is a member of the recently founded Dutch CONTRAST consortium which aims to identify and test new treatments for patients with acute ischaemic stroke or intracerebral haemorrhage through a range of follow-up trials to MR CLEAN.
Bart is President elect of the European Stroke Organisation (ESO).
Why are you excited about participating in APSC 2017?
This major stroke conference brings me back to the country where I did an internship in 1988!